The microenvironment in hairy cell leukemia: pathways and potential therapeutic targets

References

• Korsmeyer SJ, Greene WC, Cossman J, Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci USA 1983;80:4522–4526.
   PubMed Web of Science ®Google Scholar
• Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 2009;114:3367–3375.
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F, Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease? J Clin Oncol 2008;26:4497–4503.
   PubMed Web of Science ®Google Scholar
• Herreros B, Sanchez-Aguilera A, Piris MA. Lymphoma microenvironment: culprit or innocent? Leukemia 2008;22: 49–58.
   PubMed Web of Science ®Google Scholar
• Ghia P, Chiorazzi N, Stamatopoulos K. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med 2008;264:549–562.
   PubMed Web of Science ®Google Scholar
• Kim CH, Broxmeyer HE. Chemokines: signal lamps for trafficking of T and B cells for development and effector function. J Leukoc Biol 1999;65:6–15.
   PubMed Web of Science ®Google Scholar
• Durig J, Schmucker U, Duhrsen U. Differential expression of chemokine receptors in B cell malignancies. Leukemia 2001;15:752–756.
   PubMed Web of Science ®Google Scholar
• Trentin L, Cabrelle A, Facco M, Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood 2004;104:502–508.
   PubMed Web of Science ®Google Scholar
• Wong S, Fulcher D. Chemokine receptor expression in B-cell lymphoproliferative disorders. Leuk Lymphoma 2004;45:2491–2496.
   PubMed Web of Science ®Google Scholar
• Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301–314.
   PubMed Web of Science ®Google Scholar
• Csanaky G, Matutes E, Vass JA, Morilla R, Catovsky D. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia 1997;11:408–415.
   Google Scholar
• Cawley JC, Hawkins SF. The biology of hairy-cell leukaemia. Curr Opin Hematol 2010;17:341–349.
   PubMed Web of Science ®Google Scholar
• Burthem J, Cawley JC. The bone marrow fibrosis of hairy-cell leukemia is caused by the synthesis and assembly of a fibronectin matrix by the hairy cells. Blood 1994;83:497–504.
   PubMed Web of Science ®Google Scholar
• Burthem J, Baker PK, Hunt JA, Cawley JC. Hairy cell interactions with extracellular matrix: expression of specific integrin receptors and their role in the cell's response to specific adhesive proteins. Blood 1994;84:873–882.
   PubMed Web of Science ®Google Scholar
• Vincent AM, Burthem J, Brew R, Cawley JC. Endothelial interactions of hairy cells: the importance of alpha 4 beta 1 in the unusual tissue distribution of the disorder. Blood 1996;88:3945–3952.
   PubMed Web of Science ®Google Scholar
• Turley EA, Belch AJ, Poppema S, Pilarski LM. Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood 1993;81:446–453.
   PubMed Web of Science ®Google Scholar
• Aziz KA, Till KJ, Chen H, The role of autocrine FGF-2 in the distinctive bone marrow fibrosis of hairy-cell leukemia (HCL). Blood 2003;102:1051–1056.
   PubMed Web of Science ®Google Scholar
• Shehata M, Schwarzmeier JD, Hilgarth M, Hubmann R, Duechler M, Gisslinger H. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia. J Clin Invest 2004;113:676–685.
   PubMed Web of Science ®Google Scholar
• Wright DE, Bowman EP, Wagers AJ, Butcher EC, Weissman IL. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J Exp Med 2002;195:1145–1154.
   PubMed Web of Science ®Google Scholar
• Burger JA, Burkle A. The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target. Br J Haematol 2007;137:288–296.
   PubMed Web of Science ®Google Scholar
• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804–815.
   PubMed Web of Science ®Google Scholar
• Forconi F. Hairy cell leukaemia: biological and clinical overview from immunogenetic insights. Hematol Oncol 2010 Nov 2. [Epub ahead of print].
   Web of Science ®Google Scholar
• Forconi F, Sozzi E, Rossi D, Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia. Haematologica 2008;93:697–705.
   PubMed Web of Science ®Google Scholar
• Ghiotto F, Fais F, Valetto A, Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 2004;113:1008–1016.
   PubMed Web of Science ®Google Scholar
• Messmer BT, Albesiano E, Efremov DG, Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 2004;200:519–525.
   PubMed Web of Science ®Google Scholar
• Tobin G, Thunberg U, Johnson A, Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 2003;101:4952–4957.
   PubMed Web of Science ®Google Scholar
• Widhopf GF 2nd, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004;104:2499–2504.
   PubMed Web of Science ®Google Scholar
• Knight RA, Worman CP, Cawley JC. Defective autologous and allogeneic mixed lymphocyte reactions in hairy cell leukaemia. Clin Exp Immunol 1983;53:600–604.
   PubMed Web of Science ®Google Scholar
• Van De Corput L, Falkenburg JH, Kluin-Nelemans JC. T-cell dysfunction in hairy cell leukemia: an updated review. Leuk Lymphoma 1998;30:31–39.
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans JC, Kester MG, Melenhorst JJ, Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood 1996;87:3795–3802.
   PubMed Web of Science ®Google Scholar
• van de Corput L, Kluin-Nelemans HC, Kester MG, Willemze R, Falkenburg JH. Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones. Blood 1999;93:251–259.
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans HC, Beverstock GC, Mollevanger P, Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood 1994;84:3134–3141.
   PubMed Web of Science ®Google Scholar
• Burger JA, Burger M, Kipps TJ. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999;94:3658–3667.
   PubMed Web of Science ®Google Scholar
• Laird DJ, von Andrian UH, Wagers AJ. Stem cell trafficking in tissue development, growth, and disease. Cell 2008;132:612–630.
   PubMed Web of Science ®Google Scholar
• Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004;103:4389–4395.
   PubMed Web of Science ®Google Scholar
• Davis RE, Ngo VN, Lenz G, Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010;463:88–92.
   PubMed Web of Science ®Google Scholar
• Friedberg JW, Sharman J, Sweetenham J, Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood 2010;115:2578–2585.
   PubMed Web of Science ®Google Scholar
• Burger JA, O'Brien S, Fowler N, The Bruton's tyrosine kinase inhibitor, PCI-32765, is well tolerated and demonstrates promising clinical activity in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL): an update on ongoing phase 1 studies. Blood 2010;116(Suppl. 1): Abstract 57.
   Google Scholar